Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 5,848 shares at $60.91 ($356K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Scheduled sale ($356k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.91 | 2,924 | $178K | 50.0% |
| 2 | $60.91 | 2,924 | $178K | 50.0% |
| Total | $60.91 avg | 5,848 | $356K | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |